Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Jones

Showing results (351-360 of 589) with videos related to

Pageof 59
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 TrialEugene I Hwang, Marcel Kool, Peter C Burger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomasKarine Jacob, Dongh-Anh Quang-Khuong, David T W Jones, et al.
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2018
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trialH-G Wirsching, G Tabatabai, U Roelcke, et al.
Nature Communications|November 14, 2018
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumorsManasi Ratnaparkhe, John K L Wong, Pei-Chi Wei, et al.
Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.
Nature Communications|April 20, 2026
Author Correction: Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumorsManasi Ratnaparkhe, John K L Wong, Pei-Chi Wei, et al.
Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Acta Neuropathologica|November 18, 2019
YAP1-fusions in pediatric NF2-wildtype meningiomaPhilipp Sievers, Jason Chiang, Daniel Schrimpf, et al.
Pageof 59

Showing results (351-360 of 589) with videos related to

Sort By:
Pageof 59
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2018
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 TrialEugene I Hwang, Marcel Kool, Peter C Burger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomasKarine Jacob, Dongh-Anh Quang-Khuong, David T W Jones, et al.
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2018
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trialH-G Wirsching, G Tabatabai, U Roelcke, et al.
Nature Communications|November 14, 2018
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumorsManasi Ratnaparkhe, John K L Wong, Pei-Chi Wei, et al.
Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.
Nature Communications|April 20, 2026
Author Correction: Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumorsManasi Ratnaparkhe, John K L Wong, Pei-Chi Wei, et al.
Acta Neuropathologica|July 11, 2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic gliomaBenedikt Wiestler, David Capper, Martin Sill, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Acta Neuropathologica|November 18, 2019
YAP1-fusions in pediatric NF2-wildtype meningiomaPhilipp Sievers, Jason Chiang, Daniel Schrimpf, et al.
Pageof 59